- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Synta Pharmaceuticals Corp
+ Add to WatchlistSNTA:US
7.5700 USD 0.2600 3.56%As of 20:10:00 ET on 05/24/2013.
Company Profile for Synta Pharmaceuticals Corp (SNTA)
Synta Pharmaceuticals Corp. is a biopharmaceutical company developing small-molecule drugs for inflammatory diseases, cancer, and diabetes. The Company has drug candidates in human clinical trials and additional programs in preclinical studies.
Contact Information
Synta Pharmaceuticals Corp
45 Hartwell Avenue
Lexington, MA 02421
United States
Key Executives for Synta Pharmaceuticals Corp (SNTA)
| Safi R BahcallPresident/CEO/Co-Founder | Vojo VukovicSenior VP/Chief Medical Ofcr |
| Amar SinghSenior VP:Bus/Chief Bus Ofcr | Keith S EhrlichVP:Finance/CFO |
| Wendy E RiederVP:Intellectual Property/Secy |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page